No. of patients | 235 |
---|---|
Age (years when treatments started) | |
  Range | 3-82 |
  Medium | 58 |
Sex (No. (%)) | |
  Female | 137 (58,3%) |
  Male | 98 (41,7%) |
Cancer type (No. (%)) | |
  Colorectal, intestinal and anal | 42 (17,9%) |
  Ovarian (also tubal) | 35 (14,9%) |
  Breast | 29 (12,3%) |
  Sarcomas | 21 (8,9%) |
  Pancreatic and papilla vater | 20 (8,5%) |
  Lung | 18 (7,7%) |
  Neuroblastoma | 14 (6,0%) |
  Prostate | 12 (5,1%) |
  Skin and melanomas | 11 (4,7%) |
  Liver and mesothelioma | 9 (3,8%) |
  Gastric | 6 (2,6%) |
  Biliary tract or cholangio | 5 (2,1%) |
  Urinary tract or bladder | 4 (1,7%) |
  Cervix and endometrial | 3 (1,3%) |
  Renal | 3 (1,3%) |
  Thyroid, thymus or parathydoid | 2 (0,9%) |
  Esophageal | 1 (0,4%) |